Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer
出版年份 2023 全文链接
标题
Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer
作者
关键词
-
出版物
LUNG CANCER
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-02-02
DOI
10.1016/j.lungcan.2023.01.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blood protein biomarkers in lung cancer
- (2022) Hong Huang et al. CANCER LETTERS
- Therapy Monitoring of EGFR Positive Non-Small Cell Lung Cancer Patients using ddPCR Multiplex Assays Monitoring NSCLC patients by ddPCR
- (2021) Remco de Kock et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Lung Cancer in the Netherlands
- (2021) Lizza E.L. Hendriks et al. Journal of Thoracic Oncology
- Current and Future Development in Lung Cancer Diagnosis
- (2021) Reem Nooreldeen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
- (2020) Nicolas Guibert et al. European Respiratory Review
- Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer
- (2020) Sylvia A.A.M. Genet et al. Oncotarget
- Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma
- (2019) Remco de Kock et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer
- (2018) Elif Tugce Korkmaz et al. CLINICAL BIOCHEMISTRY
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine
- (2018) Anna McLean et al. Journal of Clinical Medicine
- Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
- (2018) Qixian Yang et al. DISEASE MARKERS
- Current and Prospective Protein Biomarkers of Lung Cancer
- (2017) Tatiana Zamay et al. Cancers
- Diagnostic relevance of circulating biomarkers in patients with lung cancer
- (2017) Rafael Molina et al. Cancer Biomarkers
- Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
- (2017) Rifeng Jiang et al. PLoS One
- Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
- (2016) Rafael Molina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer
- (2014) Béla Nagy et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)
- (2011) Susana Cedrés et al. Clinical Lung Cancer
- Diagnostic Workup of Lung Cancer
- (2011) David J. Sugarbaker et al. Surgical Oncology Clinics of North America
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started